Condition
Montelukast
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
P 1 (1)
P 2 (2)
P 4 (1)
Trial Status
Completed2
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06747130Phase 2Recruiting
Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue Patients
NCT05143502Phase 1UnknownPrimary
Role of Montelukast in the Management of Chronic Rhinosinusitis With Nasal Polyps.
NCT05040828Phase 4Completed
Early Intervention in Allergic Patients
NCT00656058Phase 2Completed
Montelukast to Treat Bronchiolitis Obliterans
Showing all 4 trials